1. A. K. Brel’, S. V. Lisina, Yu. N. Budaeva, et al., Zh. Obshch. Khim., 85(9), 1561 – 1563 (2015).
2. C. F. Hoyng, M. G. McKenna, and D. L. Walters, Communications, 3, 191 – 193 (1982).
3. O. Igglessi-Markopoulou and C. Sandris, J., Heterocyclic Chem., 19(4), 883 – 890 (1982); doi: https://doi.org/10.1002/jhet.5570190434.4. Patent RF 2570646 (2015).
4. Decree of the Russian Federation Ministry of Health and Social Development No. 708-n of August 23, 2010, “Approval of Rules for Laboratory Practice” [in Russian], Moscow (2010).
5. R. S. Mirzoyan, A. S. Saratikov, M. B. Plotnikov, et al., Methodological Recommendations for the Preclinical Study of Drugs for the Treatment of Impairments to Cerebral Circulation and Migraine [in Russian], Grifi K, Moscow (2012), Part 1, pp. 453 – 477.